ישראל - עברית - Ministry of Health

אי. טי. שיקום בע"מ - אחר - improve circulation/respiratory/ cardio function

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - letrozole 2.5 mg - tablets - letrozole - letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - carvedilol 12.5 mg - tablets - carvedilol - treatment of symptomatic congestive heart failure. carvedilol teva may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ace inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - aluminium oxide hydrated 200 mg; dimethicone 25 mg - chewable tablets - combinations - antacid, antiflatulent, relief of sensation of heartburn.

ישראל - עברית - Ministry of Health

cts chemical industries ltd - calcium as carbonate 500 mg - chewable tablets - calcium carbonate - antacid, calcium supplement.

ישראל - עברית - Ministry of Health

cts chemical industries ltd - calcium as carbonate 500 mg - chewable tablets - calcium carbonate - antacid, calcium supplement.

ישראל - עברית - Ministry of Health

perrigo israel agencies ltd - letrozole 2.5 mg - film coated tablets - letrozole - • femozol (letrozole tablets) is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer . • femozol is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy .• extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy .• adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer .

ישראל - עברית - Ministry of Health

rafa laboratories ltd - letrozole 2.5 mg - film coated tablets - letrozole - letrozole tablets are indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined locally advanced or metastatic breast cancer. letrozole is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - eplerenone 25 mg - film coated tablets - eplerenone - inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (lvef < 40 % ) and clinical evidence of heart failure after recent myocardial infarction.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - eplerenone 50 mg - film coated tablets - eplerenone - inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (lvef < 40 % ) and clinical evidence of heart failure after recent myocardial infarction.